Financial StabilityWith a strong cash balance and no debt, the company is well-positioned financially until 2025.
Product DevelopmentSINTX is focused on developing silicon nitride products for medical and non-medical applications, which have the potential for wide commercial opportunities.
Strategic AcquisitionThe company's acquisition of TA&T enhances capabilities in aerospace, defense, and biomedical markets, offering a diversification of revenue streams.